A new study finds that the HPV vaccine prevents genital warts and precancerous changes to the cervix in young women ages 14 to 17. Not only does this provide further evidence of the vaccine’s efficacy; it suggests that early vaccination is important.
New research finds that Black women, who are more likely to get and die from cervical cancer, are also more likely to have strains of HPV not covered by the current vaccines. However, researchers caution this is not a reason to delay getting vaccinated.
New research found that low-income parents do not get their daughters vaccinated with the HPV vaccine for a variety of reasons, including inadequate explanations by health-care providers, distrust of the government and medicine, and beliefs about pre-marital sex.
The bad news is that neck and throat cancers are rising, and this common sexually transmitted infection seems to be the cause. The good news: The vaccines that are available to prevent infection seem to protect against these kinds of cancers as well.
When it comes to HPV, somehow many parents still have it backwards—in reality, the HPV vaccine is safe, but cervical cancer is both dangerous and all too common.
In this week’s sexual health roundup: scientists use engineered stem-cells to attack HIV; California tests a new pill that prevents HIV infection when taken daily but some question how expensive it is; the CDC releases alarming data on cancers caused by HPV in women; and South Carolina lawmakers take steps to increase HPV vaccination among middle school students.
In Colombia, a bill that would introduce the vaccine into Bogotá’s public health care system has just failed for the third time.